Weimun Biotechnology
At a glance
- Status
- Operational
- Headquarters
- China
- Open positions
- None listed
- Dealroom signal
- 11.4/100
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES D✓Equity / VC | May 2023 | $14M | $55M | Sheng Yuan Zhiben · One Village Capital · Sheng Ze Investment · VVB Foundation | ↗ |
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later4 investors entered at this stage
- SZSheng Yuan Zhiben
- OCOne Village Capital
- SISheng Ze Investment
- VFVVB Foundation
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Weimun Biotechnology on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Weimun Biotechnology’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.